Institute for Radioelements (IRE) has entered into a five-year collaboration agreement to supply its molybdenum-99 (Mo-99) to Lantheus Medical Imaging.
Lantheus will use Mo-99, the parent isotope of technetium-99m (Tc-99m), in its TechneLite (Technetium Tc 99m Generator) generators.
Tc-99m is a radioisotope used in nuclear medicine diagnostic imaging tests including scans of the heart, brain, kidneys and some types of tumors.
Lantheus Medical Imaging president and CEO Jeff Bailey said the agreement with IRE further demonstrates the company's ongoing efforts and commitment to maximize global access to Mo-99.
"We are focused on enhancing our balanced and diverse supply chain for this important medical isotope to ensure that we consistently meet the needs of customers and their patients," Bailey added.
"Over the course of this agreement, IRE will also help support our strategic initiatives related to supply chain stability and the conversion to 100 percent LEU-derived Mo-99."
